Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy
2010-022558-18Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of clenbuterol in spinal and bulbar muscular atrophy (SBMA), sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoint: Change in 6-minute walk test distance at 12 months. Started Sep 2012; status: active.
02
Drugs
clenbuterol
03
Conditions
spinal and bulbar muscular atrophy (SBMA)
Beyond the preview
Go deeper on 2010-022558-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022558-18.